Home / Nervous system / Rivastigmine
ATC N06DA03 · Psychoanaleptics
Rivastigmine shortage
As of 31 Oct 2026, Rivastigmine has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 16 products.
Countries4/5
Products16packs or presentations
Short since15 Oct 20215.0 years ago
Earliest return12 Nov 2026company estimate
No return date11products
Main reasonManufacturing problem
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | RIVASTIGMINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 15 Oct 2021 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | NIMVASTID | KRKA D.D. NOVO MESTO | 21 Mar 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | RIVASTIGMINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 9 Sep 2024 | not given | Increased demand Elevata richiesta |
| IT | RIVASTIGMINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Aug 2025 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | RIVASTIGMINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Aug 2025 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | NIMVASTID | KRKA D.D. NOVO MESTO | 6 Nov 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | NIMVASTID | KRKA D.D. NOVO MESTO | 3 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RIVASTIGMINA MYLAN PHARMA | MYLAN S.P.A. | 18 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RIVASTIGMINA AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 8 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RIVASTIGMINA MYLAN PHARMA announced | MYLAN S.P.A. | 20 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | RIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulas | Laboratorio Stada S.L. | 28 Apr 2026 | 12 Nov 2026 | Not stated |
| AT | Nimvastid 1,5 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 8 Sep 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Nimvastid 6 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 8 Sep 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Rivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster, 30 Stück | Sandoz GmbH | 14 Sep 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Nimvastid 3 mg Hartkapseln, 60 Stück | KRKA d.d. Novo Mesto | 22 Oct 2026 | 30 Nov 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Rivastigmin Sandoz 9.5 mg/24 h transderm. patch sachet 90 (3 x 30 (18 mg/10 cm²)) | Sandoz | 17 Jun 2026 | 13 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.